
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+9
We are Iktos. A start-up company specializing in the development of proprietary artificial intelligence technologies and software for ligand-based and structure-based de novo drug design focusing on multi parametric optimization. Our de novo design algorithm is based on deep generative models with reinforcement learning. It designs novel and easy to make compounds, optimized to meet a given multi-objective blueprint, with unprecedented speed, performance, and diversity. Please visit our webpage to know more about our products and offerings https://iktos.ai/products
Artificial intelligence,medicinal chemistry,chemoinformatics,machine learning,deep learning,molecular modeling,cadd,mpo,de novo drug design,virtual screening,drug design,inverse-qsar,qsar,and lead optimization
Iktos operates in the Biotechnology industry.
Iktos's revenue is 11m - 100m
Iktos has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.